197 related articles for article (PubMed ID: 31546305)
1. Trehalose Protects the Probiotic Yeast
Moon JE; Heo W; Lee SH; Lee SH; Lee HG; Lee JH; Kim YJ
J Microbiol Biotechnol; 2020 Jan; 30(1):54-61. PubMed ID: 31546305
[No Abstract] [Full Text] [Related]
2. S-Adenosyl-L-methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death.
Cascio V; Gittings D; Merloni K; Hurton M; Laprade D; Austriaco N
BMC Microbiol; 2013 Feb; 13():35. PubMed ID: 23402325
[TBL] [Abstract][Full Text] [Related]
3. Preparation of
Shu G; Li B; Dai C; Chen L; Yang X; Lei Z; Zhang M; Guo Y
Prep Biochem Biotechnol; 2022; 52(9):1078-1086. PubMed ID: 35108154
[No Abstract] [Full Text] [Related]
4. Epidemiology of Saccharomyces fungemia: A systematic review.
Vinayagamoorthy K; Pentapati KC; Prakash H
Med Mycol; 2023 Feb; 61(2):. PubMed ID: 36806741
[TBL] [Abstract][Full Text] [Related]
5. Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews.
Chan MZA; Toh M; Liu SQ
Int J Food Microbiol; 2021 Jul; 350():109229. PubMed ID: 34023682
[TBL] [Abstract][Full Text] [Related]
6. Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.
Gopalan S; Ganapathy S; Mitra M; Neha ; Kumar Joshi D; Veligandla KC; Rathod R; Kotak BP
Cureus; 2023 Oct; 15(10):e46314. PubMed ID: 37927652
[TBL] [Abstract][Full Text] [Related]
7. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
Kaźmierczak-Siedlecka K; Ruszkowski J; Fic M; Folwarski M; Makarewicz W
Curr Microbiol; 2020 Sep; 77(9):1987-1996. PubMed ID: 32472262
[TBL] [Abstract][Full Text] [Related]
8. Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient.
Landaburu MF; López Daneri GA; Relloso S; Zarlenga LJ; Vinante MA; Mujica MT
Rev Argent Microbiol; 2020; 52(1):27-30. PubMed ID: 31262611
[TBL] [Abstract][Full Text] [Related]
9. Review article: yeast as probiotics -- Saccharomyces boulardii.
Czerucka D; Piche T; Rampal P
Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
[TBL] [Abstract][Full Text] [Related]
10. Enhancing probiotic impact: engineering
de Carvalho BT; Subotić A; Vandecruys P; Deleu S; Vermeire S; Thevelein JM
Appl Environ Microbiol; 2024 Jun; 90(6):e0032524. PubMed ID: 38752748
[No Abstract] [Full Text] [Related]
11. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP
Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive optimization of composite cryoprotectant for
Guowei S; Yang X; Li C; Huang D; Lei Z; He C
Prep Biochem Biotechnol; 2019; 49(9):846-857. PubMed ID: 31244369
[No Abstract] [Full Text] [Related]
13. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic.
Wombwell E; Bransteitter B; Gillen LR
Mycoses; 2021 Dec; 64(12):1521-1526. PubMed ID: 34585799
[TBL] [Abstract][Full Text] [Related]
14. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
[TBL] [Abstract][Full Text] [Related]
15. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.
Jin Y; Yu S; Liu JJ; Yun EJ; Lee JW; Jin YS; Kim KH
Microb Cell Fact; 2021 Aug; 20(1):160. PubMed ID: 34407819
[TBL] [Abstract][Full Text] [Related]
16. Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline.
Roy Sarkar S; Mitra Mazumder P; Chatterjee K; Sarkar A; Adhikary M; Mukhopadhyay K; Banerjee S
Physiol Behav; 2021 Jul; 236():113411. PubMed ID: 33811908
[TBL] [Abstract][Full Text] [Related]
17. The Effect of a Yeast Probiotic on Acute Diarrhea in Children.
Sharif MR; Kashani HH; Ardakani AT; Kheirkhah D; Tabatabaei F; Sharif A
Probiotics Antimicrob Proteins; 2016 Dec; 8(4):211-214. PubMed ID: 27530282
[TBL] [Abstract][Full Text] [Related]
18. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
Sen S; Mansell TJ
Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
[TBL] [Abstract][Full Text] [Related]
19. Saccharomyces boulardii CNCM I-745 probiotic does not alter the pharmacokinetics of amoxicillin.
Selig DJ; DeLuca JP; Li Q; Lin H; Nguyen K; Scott SM; Sousa JC; Vuong CT; Xie LH; Livezey JR
Drug Metab Pers Ther; 2020 Mar; 35(1):. PubMed ID: 32134728
[TBL] [Abstract][Full Text] [Related]
20. Saccharomyces boulardii as therapeutic alternative in experimental giardiasis.
Ribeiro MRS; Oliveira DR; Caliari MV; Cara Machado DC; Andrade MER; Cardoso VN; Dos Santos Martins F; Nicoli JR; Gomes MA
J Appl Microbiol; 2021 Jul; 131(1):460-469. PubMed ID: 33289232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]